# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and maintai...
Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of...
Aims To Improve Patient Quality Of Life For Those With Spinal Cord And Brain Injuries, Multi-Trauma, Amputations, Stroke, Multi...
Lake Street analyst Ben Haynor initiates coverage on Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy rating and announces Pri...
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and raises t...